Reply to Dr. Chelly

Regional Anesthesia and Pain Medicine

Volumn 35, Issue 4, 2010, Pages 402-403

  Horlocker, Terese T ^a   Wedel, Denise J ^a   Enneking, F Kayser ^b   Rowlingson, John C ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; FONDAPARINUX;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; HUMAN; LETTER; NERVE BLOCK; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RETROPERITONEAL HEMATOMA; RISK BENEFIT ANALYSIS; THROMBOSIS PREVENTION;

EID: 77954398483     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181e90e01     Document Type: Letter

References (3)

1. Chelly JE. The most recent recommendations for deep blocks and thromboprophylaxis: evidence not supporting a quot;thromboprophylaxis therapeutic windowquot; [letter to the editor]. Reg Anesth Pain Med. 2010;35:402.
2. Horlocker TT, Wedel DJ, Rowlingson J, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (third edition). Reg Anesth Pain Med. 2010;35:64-101.
3. Chelly JE, Schilling D. Thromboprophylaxis and peripheral nerve blocks in patients undergoing joint arthroplasty. J Arthroplasty. 2008;23:350-354.